BCR and autoimmune disease: We demonstrated that TLR signaling is important in hBtk-mediated autoimmune disease, although the in vitro BCR responsiveness of CD19-hBtk B cells, including downstream signaling, survival and proliferation, was enhanced in a MyD88-independent fashion.